Abstract
AbstractThis study investigates brain network alterations in the default mode-like network (DMLN) at early stages of disease progression in a rat model of Alzheimer’s disease (AD) with application in the development of early diagnostic biomarkers of AD in translational studies. Thirteen male TgF344-AD (TG) rats, and eleven male wild-types (WT) littermates underwent longitudinal resting-state fMRI at the age of 4 and 6 months (pre and early-plaque stages of AD). Alterations in connectivity within DMLN were characterized by calculating the nodal degree (ND), a graph theoretical measure of centrality. The ND values of the left CA2 subregion of the hippocampus was found to be significantly lower in the 4-month-old TG cohort compared to the age-matched WT littermates. Moreover, a lower ND value (hypo-connectivity) was observed in the right prelimbic cortex (prL) and basal forebrain in the 6-month-old TG cohort, compared to the same age WT cohort. Indeed, the ND pattern in the DMLN in both TG and WT cohorts showed significant differences across the two time points that represent pre-plaque and early plaque stages of disease progression. Our findings indicate that lower nodal degree (hypo-connectivity) in the left CA2 in the pre-plaque stage of AD and hypo-connectivity between the basal forebrain and the DMLN regions in the early-plaque stage demonstrated differences in comparison to healthy controls. These results suggest that a graph-theoretical measure such as the nodal degree, can characterize brain networks and improve our insights into the mechanisms underlying Alzheimer’s disease.
Funder
Internationale Stichting Alzheimer Onderzoek
Publisher
Springer Science and Business Media LLC
Reference86 articles.
1. Mattson, M. P. Pathways towards and away from Alzheimer’s disease. Nature 430, 631–639 (2004).
2. Barage, S. H. & Sonawane, K. D. Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer’s disease. Neuropeptides 52, 1–18 (2015).
3. Kumar, A. & Singh, A. A review on Alzheimer’s disease pathophysiology and its management: an update. Pharmacol. Rep. 67, 195–203 (2015).
4. Vemuri, P., Jones, D. T. & Jack, C. R. Resting state functional MRI in Alzheimer’s Disease. Alzheimer’s Res. Ther. 4, 1–9 (2012).
5. Ibrahim, B. et al. Diagnostic power of resting‐state fMRI for detection of network connectivity in Alzheimer’s disease and mild cognitive impairment: A systematic review. Hum. Brain Mapping 42, 2941–2968 (2021).